Patents by Inventor Ferdinand Edward MASSARI

Ferdinand Edward MASSARI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease
    Patent number: 11813272
    Abstract: Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.
    Type: Grant
    Filed: November 17, 2020
    Date of Patent: November 14, 2023
    Assignee: Flagship Pioneering Innovations V, Inc.
    Inventors: Steven John Taylor, John Robert Proudfoot, Mi-Jeong Kim, Kathleen Nudel, Timothy F. Briggs, Afrand Kamali Sarvestani, Leonard Buckbinder, Bernard Lanter, Ferdinand Edward Massari, Koji Yasuda, Spencer Cory Peck, Cheri Snedeker, Diana Le, Jessica Alexander, Anna Liang, Dinara Gunasekera, David Arthur Berry, John Patrick Casey, Jr.
  • MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME
    Publication number: 20230293458
    Abstract: Multibiotic agents are disclosed. The multibiotic agents may contain two or more moieties linked through bonds cleavable in vivo. The bonds cleavable in vivo can be ester bonds, amide bonds, azo bonds, glycosidic bonds, carbonate linkers, or carbamate linkers. The moieties can be alcohol cores, amine cores, and/or acyls. Also disclosed are compositions containing multibiotic agents and methods of using the multibiotic agents.
    Type: Application
    Filed: May 25, 2023
    Publication date: September 21, 2023
    Inventors: John Patrick CASEY, David Arthur BERRY, Alfredo CASTRO, Steven John TAYLOR, Ferdinand Edward MASSARI, John Robert PROUDFOOT, Elijah Lane BOGART, Timothy F. BRIGGS
  • ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE
    Publication number: 20210177877
    Abstract: Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.
    Type: Application
    Filed: November 17, 2020
    Publication date: June 17, 2021
    Inventors: Steven John TAYLOR, John Robert PROUDFOOT, Mi-Jeong KIM, Kathleen NUDEL, Timothy F. BRIGGS, Afrand KAMALI SARVESTANI, Leonard BUCKBINDER, Bernard LANTER, Ferdinand Edward MASSARI, Koji YASUDA, Spencer Cory PECK, Cheri SNEDEKER, Diana LE, Jessica ALEXANDER, Anna LIANG, Dinara GUNASEKERA, David Arthur BERRY, John Patrick CASEY, JR.
  • CONJUGATES AND METHODS OF USING THE SAME
    Publication number: 20210162057
    Abstract: Disclosed are conjugates including a recognition element covalently bonded to or linked through a linker to a payload. The payload is a pharmaceutical agent (e.g., an antineoplastic agent, anti-infective agent, or anti-inflammatory agent) or a diagnostic agent. Also disclosed are methods of using the conjugates.
    Type: Application
    Filed: February 11, 2021
    Publication date: June 3, 2021
    Inventors: Spencer Cory PECK, Steven John TAYLOR, Elijah Lane BOGART, Devin Forest Reed DOUD, Joo Hyun IM, Dervla Tamara ISAAC, Jenny LIU, Ferdinand Edward MASSARI, Robert Walter MYERS, John Robert PROUDFOOT, Cheri Ross, John Patrick CASEY, JR., David Arthur BERRY
  • ACYLATED CATECHIN POLYPHENOLS AND METHODS OF THEIR USE FOR THE TREATMENT OF CANCER
    Publication number: 20210085640
    Abstract: Disclosed herein are acylated active agents and methods of their use, e.g., for modulating a cancer marker or for treating cancer.
    Type: Application
    Filed: December 3, 2020
    Publication date: March 25, 2021
    Inventors: Steven John TAYLOR, Leonard BUCKBINDER, John Robert PROUDFOOT, Mi-Jeong KIM, Timothy F. BRIGGS, Ferdinand Edward MASSARI, Spencer Cory PECK, Koji YASUDA, Amir MOAREFI, David Arthur BERRY, John Patrick CASEY, JR.
  • Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease
    Patent number: 10953027
    Abstract: Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.
    Type: Grant
    Filed: February 27, 2020
    Date of Patent: March 23, 2021
    Assignee: Flagship Pioneering Innovations V, Inc.
    Inventors: Steven John Taylor, John Robert Proudfoot, Mi-Jeong Kim, Kathleen Nudel, Timothy F. Briggs, Afrand Kamali Sarvestani, Leonard Buckbinder, Bernard Lanter, Ferdinand Edward Massari, Koji Yasuda, Spencer Cory Peck, Cheri Snedeker, Diana Le, Jessica Alexander, Anna Liang, Dinara Gunasekera, David Arthur Berry, John Patrick Casey, Jr.
  • ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE
    Publication number: 20200197428
    Abstract: Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.
    Type: Application
    Filed: February 27, 2020
    Publication date: June 25, 2020
    Inventors: Steven John TAYLOR, John Robert PROUDFOOT, Mi-Jeong KIM, Kathleen NUDEL, Timothy F. BRIGGS, Afrand KAMALI SARVESTANI, Leonard BUCKBINDER, Bernard LANTER, Ferdinand Edward MASSARI, Koji YASUDA, Spencer Cory PECK, Cheri SNEDEKER, Diana LE, Jessica ALEXANDER, Anna LIANG, Dinara GUNASEKERA, David Arthur BERRY, John Patrick CASEY, JR.
  • MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME
    Publication number: 20200101030
    Abstract: Multibiotic agents are disclosed. The multibiotic agents may contain two or more moieties linked through bonds cleavable in vivo. The bonds cleavable in vivo can be ester bonds, amide bonds, azo bonds, glycosidic bonds, carbonate linkers, or carbamate linkers. The moieties can be alcohol cores, amine cores, and/or acyls. Also disclosed are compositions containing multibiotic agents and methods of using the multibiotic agents.
    Type: Application
    Filed: December 3, 2019
    Publication date: April 2, 2020
    Inventors: John Patrick CASEY, JR., David Arthur BERRY, Alfredo CASTRO, Steven John TAYLOR, Ferdinand Edward MASSARI, John Robert PROUDFOOT, Elijah Lane BOGART, Timothy F. BRIGGS